A swiss pharmaceutical company called Novartis is licensing Google’s technology to create special contact lenses for diabetic patients. The new lenses will analyze tear fluid in the eye and provide real-time, constant measurement of an individual’s glucose levels. That data will then be transmitted wirelessly to a mobile, enabling users to monitor their condition easily.
This new technology will be used to treat people with presbyopia, who can no longer read without glasses, and is even considering the possibility of implanting the lens directly into the eye. For anyone with diabetes, this could be the greatest treatment advance since the insulin pump.
The technology is still very much in its infancy—you can be sure it’ll take a while to get FDA approval—but this is a big step forwards.